COVID-19 and the Cancer Patient

Ianniello, Nicole

doi:10.34297/ajbsr.2021.13.001916

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the future, physicians and medical researchers might be able to assess a patient's condition more clearly and rapidly if they were provided access to personal vital signs detection devices, as can be found on many current smart watches. Those with cancer may need particular attention [83][84][85].…”

Section: Discussionmentioning

confidence: 99%

Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements

Schumm

2023

AJBSR

View full text Add to dashboard Cite

In much of the current scientific literature on COVID-19, potential treatments are studied singly or in combination with two or three other items. Treatment options for unvaccinated individuals at high risk for COVID-related complications and mortality have improved but may still be limited for remote locations. A case study of an unvaccinated older male with co-morbidities at higher risk for COVID-19 related mortality is used to illustrate possible solutions to some of the issues. His vital signs, including O 2 saturation, breathing rate, heart rate variability, night skin temperature, and resting heart rate, were monitored for 30 days before and after COVID-19 infection, providing more individual details than available in most studies to date. Supplements may have limited his vulnerability to COVID-19 while monoclonal antibodies led to rapid improvement in multiple vital signs. Tests for COVID-19 may not detect the earliest stages of COVID infection as fever levels increased before the patient tested positive for COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements

Schumm

2023

AJBSR

View full text Add to dashboard Cite

show abstract

COVID-19 and the Cancer Patient

Cited by 1 publication

References 6 publications

Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements

Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements

Contact Info

Product

Resources

About